Market Overview

NextGen Healthcare Releases Significant Product Enhancements to its EHR-agnostic Mobile Suite, Including Support for Inpatient Workflows and ICD-10 Coding

Share:

Quality Systems, Inc. (NASDAQ:QSII), known to its clients as NextGen
Healthcare, today announced significant product enhancements to its
mobile workflow solution, including new functionality that enables
physicians to utilize speech-driven documentation support in both clinic
and hospital settings and facilitates the management of ICD-10 diagnoses
to accelerate billing. The new functionality drives time savings for
caregivers by increasing workflow efficiency, improving access to
patient information and streamlining common clinic and administrative
tasks.

This press release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20171116005714/en/

NextGen Healthcare's mobile suite helps providers across the continuum of care regain time so they c ...

NextGen Healthcare's mobile suite helps providers across the continuum of care regain time so they can focus on what matters most, delivering exceptional patient care. (Photo: Business Wire)

This platform upgrade is the first major product enhancement from
Entrada following its acquisition by NextGen Healthcare, earlier this
year.

Providers often work from multiple care settings – including outpatient
clinics, surgery centers and hospitals – each with unique workflows and
charting requirements. NextGen Mobile Suite now provides clinical
documentation support specifically for the hospital setting, enabling
providers to switch between inpatient and outpatient use cases from
within a single mobile interface. With real-time access to the hospital
census list, providers can use speech-driven documentation options
(speech-to-text, transcription and remote scribe) to capture robust
patient notes at the point-of-care during hospital rounds.

In addition to inpatient support, NextGen Mobile Suite now provides
mobile access to the industry-leading IMO Problem IT Terminology
diagnosis entry tool, powered by Intelligent Medical Objects, Inc.
(IMO). The tool is embedded directly inside the platform, allowing users
to expedite and simplify entering diagnosis codes into their EHRs. The
tool, with more than 800,000 unique clinical concepts and 1.8+ million
synonyms, ensures the accurate capture of physicians' narrative and
integration with EHR terminology.

Other new product enhancements allow providers to:

  • Enable physicians to electronically sign documents from the mobile
    device.
  • Annotate on clinical images captured from Entrada prior to sending to
    the EHR.
  • Utilize fast and secure finger-print login on physicians' mobile
    devices.

"Industry dynamics are requiring physicians to be proficient in
technology across multiple systems, devices and care settings. Our goal
is simple – to provide easy-to-use solutions that allow clinicians to
remain focused on delivering quality patient care and practice
meaningful medicine," said Rusty Frantz, President and CEO of NextGen
Healthcare. "With these new enhancements, our platform allows
physicians, and their entire care team, to remain productive by reducing
the administrative burden, ultimately enabling better workflow
management across systems, both in the ambulatory and inpatient setting
alike."

SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS

This news release may contain forward-looking statements within the
meaning of the federal securities laws, including but not limited to,
statements made by Rusty Frantz, President and CEO, statements regarding
enhancements to the Company's Entrada product, and other statements
regarding future events, developments in the Company's business and in
the overall healthcare sector, the Company's future performance, as well
as management's expectations, beliefs, intentions, plans, estimates or
projections relating to the future. The Company cautions investors not
to place undue reliance on any such forward-looking statements, which
are based on information available at the time those statements are made
or management's good faith belief as of that time with regard to future
events, and should not be read as a guarantee of future performance or
results. Risks and uncertainties exist that may cause the results to
differ materially from those set forth in these forward-looking
statements. Factors that could cause the anticipated results to differ
from those described in the forward-looking statements and additional
risks and uncertainties are set forth in Part I, Item A of our most
recent Annual Report on Form 10-K and subsequently filed Quarterly
Reports on Form 10-Q, including but not limited to: the volume and
timing of systems sales and installations; length of sales cycles and
the installation process; the possibility that products will not achieve
or sustain market acceptance; seasonal patterns of sales and customer
buying behavior; impact of incentive payments under The American
Recovery and Reinvestment Act on sales and the ability of the Company to
meet continued certification requirements; the development by
competitors of new or superior technologies; the timing, cost and
success or failure of new product and service introductions, development
and product upgrade releases; undetected errors or bugs in software;
product liability; changing economic, political or regulatory influences
in the health-care industry; changes in product-pricing policies;
availability of third-party products and components; competitive
pressures including product offerings, pricing and promotional
activities; the Company's ability or inability to attract and retain
qualified personnel; possible regulation of the Company's software by
the U.S. Food and Drug Administration; changes of accounting estimates
and assumptions used to prepare the prior periods' financial statements;
disruptions caused by acquisitions of companies, products, or
technologies; and general economic conditions. These forward-looking
statements speak only as of the date hereof. The Company undertakes no
obligation to publicly update any forward-looking statements, whether as
a result of new information, future events or otherwise.

About Quality Systems, Inc.

Quality Systems, Inc., known to its clients as NextGen Healthcare,
provides a range of software, services, and analytic solutions to
medical and dental group practices. The Company's portfolio delivers
foundational capabilities to empower physician success, enrich the
patient care experience and enable the transition to value-based
healthcare. Visit www.qsii.com
and www.nextgen.com
for additional information.

About Intelligent Medical Objects, Inc. (IMO)

Intelligent Medical Objects, Inc. (IMO), is the developer of the most
widely-accepted medical terminology solution for the management of
medical vocabularies and software applications at healthcare
organizations worldwide. IMO's terminology is used by more than 3,500
hospitals and 450,000 physicians daily, and this trusted terminology
platform supports innovations by provider systems. IMO medical
vocabulary and mapping products effectively capture clinical intent and
help EMRs preserve and communicate this across the entire spectrum of
care. IMO clinical terms are mapped to all standard coding systems
including ICD-9, ICD-10, and SNOMED®. The accuracy of IMO's interface
terminology was found to be "nearly perfect" in an independent study
published by the US Centers for Disease Control. Visit www.e-imo.com.

View Comments and Join the Discussion!